En Ze Jia Shi Pharmaceuticals gets patent for Gliclazide
Gliclazide is commonly used to control mild to moderate adult-onset type 2 diabetes. Lotus Pharma’s new controlled-release Gliclazide tablet is formulated using osmotic pump technology, which encases the
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.